Ciba-Geigy and Sandoz to merge into pounds 40bn giant

Pharmaceutical fusion: Biggest merger in history will create `Novartis', the world's second-largest drugs group, while bid spotlight turns on Zeneca

MAGNUS GRIMOND

Ciba-Geigy and Sandoz of Switzerland rocketed into the record books yesterday after unveiling a pounds 40bn merger plan to create the world's second- largest drugs group. If completed, the deal would easily be the largest merger on record, but is likely to spell job losses in the UK.

The companies warned that around 10 per cent of the combined workforce, or 13,000 people world-wide, could be sacked. This may have implications in the UK, where the two companies have 6,000 staff.

The new company, to be called Novartis, would rank second only in market share to Glaxo Wellcome, itself the creation of a pounds 9.3bn takeover last year. The deal will be scrutinised closely by competition authorities in Europe and the US.

News of the merger affected pharmaceuticals shares across Europe as dealers expected it to trigger another wave of consolidation in the pharmaceuticals industry. Before a lull in the recent merger mania, around $80bn of deals have been done in the industry in the past three years. Shares in Zeneca of the UK and Schering of Germany rose sharply yesterday. Both are seen as vulnerable to takeover due to their relatively small size compared with the emerging industry giants. Meanwhile, there were falls for potential predators, such as Roche, a Swiss rival to Ciba that has long been tipped as a bidder for Zeneca, and Glaxo Wellcome.

The recent wave of consolidation has come in the wake of the decelleration in the drugs market in the 1990s in the face of increased governmental and consumer attempts to reduce ballooning health-care budgets. This has increased the pressure on companies to cut costs. Ciba and Sandoz said their merger would release SFr1.8bn (pounds 1bn) in synergy benefits over three years, with half coming in the first 18 months.

Peter Laing, an analyst with Salomon Brothers, said the latest deal showed that "consolidation in the industry hasn't gone away and the pressure to cut costs hasn't gone away. So I don't think this will be the last."

Middle-sized companies such as Novo of Denmark, Sanofi of France and Schering would all be wondering where their future lay, he suggested. By the end of the century, the top 10 drugs companies would each command world-wide market shares of between 5 and 10 per cent, rather than the 3 to 4 per cent typical now, he forecast.

Novartis would have had annual sales of SFr36bn (pounds 20bn) had it been in existence last year, but Ciba-Geigy plans to split off its speciality chemicals division and Novartis will divest its construction chemicals business, leaving turnover of SFr26bn. The new company will focus on pharmaceuticals and agrochemicals, where it will lead the world market.

Sandoz shareholders will receive 55 per cent of the new company's shares and Ciba shareholders 45 per cent. Ciba's chairman, Alex Krauer, will become Novartis chairman and Sandoz chief executive, Daniel Vasella, is to be head of the executive committee. Both companies yesterday announced profit increases for 1995. Ciba Geigy's net profits rose 13 per cent to SFr2.16bn, while Sandoz grew 18 per cent to SFr2.04bn. Based on 1995 figures, Novartis would therefore have net income of SFr4.2bn and a dowry of SFr15bn in cash and marketable securities.

The merger was welcomed by analysts, who highlighted the complementary nature of the two companies' product areas. However, they pointed out that Ciba, for one, may have been pushed to pursue a deal as two of its five most promising new drugs are facing problems. Selfotel, a treatment for strokes, has been withdrawn after poor clinical results last year and Hirudin, an anti-blood clotting drug, may have to be abandoned if results out this month do not live up to expectations.

Novartis expects to have strong positions in seven therapeutic areas, Ciba-Geigy and Sandoz said. Most of the group's top 10 products are expected to achieve double-digit growth. They include Voltaren, Ciba's arthritis and rheumatism treatment, which achieved sales of SFr1.5bn last year, and Sandimmun/Neoral, which notched up SFr1.4bn.

In the UK, the two groups are better known for consumer brands such as Lypsyl, Savlon and Nicotinell, the anti-smoking patches, which are all part of the Ciba portfolio, and Sandoz's Ovaltine. The Ciba workforce in the UK looks the more vulnerable to any job cuts. The company has seven manufacturing sites employing around 4,500, compared with Sandoz's 1,500 employees in the UK.

The Transport & General Workers Union, which has a substantial membership at the two companies, said it expected job losses.

Top 10 Novartis drugs Product Disease area 1 Voltaren Inflammation, pain 2 Sandimmun/ Neoral Transplants 3 Tegretol Nervous system 4 Nitroderm TTS Cardiovascular 5 Leponex/ Clozaril nervous system 6 Zaditen Inflammation, respitory 7 Estraderm Hormone replacement 8 Lamisil Dermatology 9 Cibacen/ Lotensin Cardiovascular 10 Parlodel nervous system

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
Arts and Entertainment
Caroline Flack became the tenth winner of Strictly Come Dancing
tvReview: 'Absolutely phenomenal' Xtra Factor presenter wins Strictly Come Dancing final
Arts and Entertainment
The Apprentice finalists Mark Wright and Bianca Miller
tvBut who should win The Apprentice?
News
The monkey made several attempts to revive his friend before he regained consciousness
video
Extras
indybest
News
Elton John and David Furnish will marry on 21 December 2014
peopleSinger posts pictures of nuptials throughout the day
Sport
Brendan Rodgers looks on from the touchline
SPORT
Life and Style
A still from the 1939 film version of Margaret Mitchell's 'Gone with the Wind'
life
ebooks
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Carlton Senior Appointments: Private Banking Manager - Intl Bank - Los Angeles

$200 - $350 per annum: Carlton Senior Appointments: Managing Producer – Office...

Carlton Senior Appointments: San Fran - Investment Advisor – Ind Advisory Firm

$125 - $225 per annum: Carlton Senior Appointments: San Fran - Investment Advi...

Sheridan Maine: Commercial Finance Manager

Up to £70,000 per annum + benefits: Sheridan Maine: Are you a qualified accoun...

Sheridan Maine: Regulatory Reporting Accountant

Up to £65,000 per annum + benefits: Sheridan Maine: Are you a qualified accoun...

Day In a Page

The week Hollywood got scared and had to grow up a bit

The week Hollywood got scared and had to grow up a bit

Sony suffered a chorus of disapproval after it withdrew 'The Interview', but it's not too late for it to take a stand, says Joan Smith
From Widow Twankey to Mother Goose, how do the men who play panto dames get themselves ready for the performance of a lifetime?

Panto dames: before and after

From Widow Twankey to Mother Goose, how do the men who play panto dames get themselves ready for the performance of a lifetime?
Thirties murder mystery novel is surprise runaway Christmas hit

Thirties murder mystery novel is surprise runaway Christmas hit

Booksellers say readers are turning away from dark modern thrillers and back to the golden age of crime writing
Anne-Marie Huby: 'Charities deserve the best,' says founder of JustGiving

Anne-Marie Huby: 'Charities deserve the best'

Ten million of us have used the JustGiving website to donate to good causes. Its co-founder says that being dynamic is as important as being kind
The botanist who hunts for giant trees at Kew Gardens

The man who hunts giants

A Kew Gardens botanist has found 25 new large tree species - and he's sure there are more out there
The 12 ways of Christmas: Spare a thought for those who will be working to keep others safe during the festive season

The 12 ways of Christmas

We speak to a dozen people who will be working to keep others safe, happy and healthy over the holidays
Birdwatching men have a lot in common with their feathered friends, new study shows

The male exhibits strange behaviour

A new study shows that birdwatching men have a lot in common with their feathered friends...
Diaries of Evelyn Waugh, Virginia Woolf and Noël Coward reveal how they coped with the December blues

Famous diaries: Christmas week in history

Noël Coward parties into the night, Alan Clark bemoans the cost of servants, Evelyn Waugh ponders his drinking…
From noble to narky, the fall of the open letter

From noble to narky, the fall of the open letter

The great tradition of St Paul and Zola reached its nadir with a hungry worker's rant to Russell Brand, says DJ Taylor
A Christmas ghost story by Alison Moore: A prodigal daughter has a breakthrough

A Christmas ghost story by Alison Moore

The story was published earlier this month in 'Poor Souls' Light: Seven Curious Tales'
Marian Keyes: The author on her pre-approved Christmas, true love's parking implications and living in the moment

Marian Keyes

The author on her pre-approved Christmas, true love's parking implications and living in the moment
Bill Granger recipes: Our chef creates an Italian-inspired fish feast for Christmas Eve

Bill Granger's Christmas Eve fish feast

Bill's Italian friends introduced him to the Roman Catholic custom of a lavish fish supper on Christmas Eve. Here, he gives the tradition his own spin…
Liverpool vs Arsenal: Brendan Rodgers is fighting for his reputation

Rodgers fights for his reputation

Liverpool manager tries to stay on his feet despite waves of criticism
Amir Khan: 'The Taliban can threaten me but I must speak out... innocent kids, killed over nothing. It’s sick in the mind'

Amir Khan attacks the Taliban

'They can threaten me but I must speak out... innocent kids, killed over nothing. It’s sick in the mind'
Michael Calvin: Sepp Blatter is my man of the year in sport. Bring on 2015, quick

Michael Calvin's Last Word

Sepp Blatter is my man of the year in sport. Bring on 2015, quick